KPMG Partnership Enables Hippocratic AI Adoption

Diving deeper into

Hippocratic AI

Company Report
This partnership creates a turnkey path to markets with severe healthcare staffing shortages, including the UK's NHS, Gulf Cooperation Council countries, and Singapore's healthcare system.
Analyzed 5 sources

The KPMG tie up matters because it turns Hippocratic AI from a U.S. vendor selling pilots into a cross border implementation package that governments can actually buy. National health systems do not just need a model, they need workflow redesign, procurement support, and local change management. That is especially valuable in markets where staffing gaps are already large, such as England, where the NHS reported about 100,100 vacancies in March 2025, including 25,600 nursing vacancies.

  • Hippocratic sells non diagnostic voice and text agents that do post discharge follow up, medication reminders, pre op instructions, and chronic care check ins at $9 per agent hour. That makes the product easier to position in shortage markets as labor backfill for repetitive outreach, not as a new clinical system.
  • The partnership is practical because KPMG already works with public sector health buyers across more than 40 countries and is explicitly positioning the alliance around staffing shortages. In government healthcare, the hard part is often mapping who does what, what data moves where, and how frontline teams adopt the tool.
  • The named regions all have visible labor pressure. Singapore raised pay for 63,000 public healthcare workers in 2025 to improve retention, while its public system is still expanding capacity. That is the kind of environment where automated patient outreach and care coordination can be framed as capacity creation rather than simple cost cutting.

From here, the likely path is that Hippocratic uses KPMG to win ministry level beachheads in centralized systems first, then expands from a few narrow workflows into broader national call, messaging, and care coordination programs. If that works, international public health systems could become a major distribution channel, not just a set of one off overseas deals.